antibodies for medical purposes; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of central nervous system (CNS) diseases; pharmaceutical preparations for the treatment of inflammatory diseases